Research Funding

  • July 15, 2009 - June 30, 2014 - The Response of Cancer and Stem/Progenitor Cells to Telomere Disruption, Principal Investigator. Sponsor: NIH/NCI, Sponsor Award ID: K08CA134552
  • July 15, 2009 - June 30, 2014 - The Response of Cancer and Stem/Progenitor Cells to Telomere Disruption, Principal Investigator. Sponsor: NIH/NCI, Sponsor Award ID: K08CA134552
  • July 15, 2009 - June 30, 2014 - The Response of Cancer and Stem/Progenitor Cells to Telomere Disruption, Principal Investigator. Sponsor: NIH/NCI, Sponsor Award ID: K08CA134552

Education

Swarthmore College, Swarthmore, PA, BA, 1995, Biology
Duke University, Durham, NC, PhD, 2002, Microbiology
Duke University, Durham, NC, MD, 2003, Medicine
University of California, San Francisco, CA, Resident/Fellow, 2003-2006, Anatomic Pathology
University of California, San Francisco, CA, Postdoctoral Fellow, 2005-2008, Biochemistry

Honors & Awards

  • 1995
    Phi Beta Kappa honor society
  • 1995
    Sigma Xi honor society
  • 1996-2003
    Medical Scientist Training Program Fellowship
  • 2005
    Ruth L. Kirschstein Postdoctoral Fellowship (declined)
  • 2005-2008
    American Cancer Society Postdoctoral Fellowship
  • 2010-present
    Mentored Clinical Scientist Development Award (K08)

Selected Publications

  1. Greenland NY, Cowan JE, Chan E, Carroll PR, Stohr BA, Simko JP Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category.  View on PubMed
  2. Anderson JA, Matoso A, Murati Amador BI, Cheng L, Stohr BA, Chan E, Osunkoya AO Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study.  View on PubMed
  3. D. Natesan, L. Zhang, H. Martell, P. Devine, B. Stohr, J. Grenert, J. Van Ziffle, N. Joseph, B.C. Bastian, S. Umetsu, C. Onodera, E. Chan, A. Desai, S. Porten, J. Chou, T. Friedlander, L. Fong, E.J. Small, A. Sweet-Cordero, V.S. Koshkin APOBEC signatures and high tumour mutational burden as predictors of clinical outcomes and response to therapy in patients with urothelial carcinoma.  View on PubMed
  4. Sangoi AR, Chan E, Stohr BA, Kunju LP Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin.  View on PubMed
  5. Divya Natesan, Henry Martell, Patrick Devine, Bradley A. Stohr, James P. Grenert, Jessica Van Ziffle, Nancy M. Joseph, Boris C. Bastian, Sarah E Umetsu, Courtney Onodera, Emily Chan, Arpita Desai, Anthony C. Wong, Sima P. Porten, Jonathan Chou, Terence W. Friedlander, Eric Jay Small, Lawrence Fong, Eric Alejandro Sweet-Cordero, Vadim S Koshkin Correlation of tumor mutational burden (TMB) with molecular profiling and clinical characteristics in patients with bladder cancer.  View on PubMed
  6. Lei L, Stohr BA, Berry S, Lockwood CM, Davis JL, Rudzinski ER, Kunder CA Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma.  View on PubMed
  7. Chan E, Stohr BA, Croom NA, Cho SJ, Garg K, Troxell ML, Higgins JP, Bean GR Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.  View on PubMed
  8. Shah RB, Stohr BA, Tu ZJ, Gao Y, Przybycin CG, Nguyen J, Cox RM, Rashid-Kolvear F, Weindel MD, Farkas DH, Trpkov K, McKenney JK "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.  View on PubMed
  9. Chan E, Garg K, Stohr BA Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.  View on PubMed
  10. Greenland NY, Cowan JE, Zhang L, Carroll PR, Chan E, Stohr BA, Simko JP Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4.  View on PubMed
  11. Chen F, Jimenez RJ, Sharma K, Luu HY, Hsu BY, Ravindranathan A, Stohr BA, Willenbring H Broad Distribution of Hepatocyte Proliferation in Liver Homeostasis and Regeneration.  View on PubMed
  12. Ravindranathan A, Diolaiti ME, Cimini BA, Stohr BA In Situ Visualization of Telomere Length, Telomere Elongation, and TERT Expression in Single Cells.  View on PubMed
  13. Fergus KB, Lee AW, Baradaran N, Cohen AJ, Stohr BA, Erickson BA, Mmonu NA, Breyer BN Pathophysiology, Clinical Manifestations, and Treatment of Lichen Sclerosus: A Systematic Review.  View on PubMed
  14. Sirohi D, Devine P, Grenert JP, van Ziffle J, Simko JP, Stohr BA TP53 structural variants in metastatic prostatic carcinoma.  View on PubMed
  15. Greenland NY, Zhang L, Cowan JE, Carroll PR, Stohr BA, Simko JP Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate Cancer.  View on PubMed
  16. Davis JL, Lockwood CM, Stohr B, Boecking C, Al-Ibraheemi A, DuBois SG, Vargas SO, Black JO, Cox MC, Luquette M, Turpin B, Szabo S, Laetsch TW, Albert CM, Parham DM, Hawkins DS, Rudzinski ER Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors.  View on PubMed
  17. Kyle Brian Zuniga, Samuel L. Washington, Jeffry Simko, Nancy Greenland, Bradley A. Stohr, Janet E. Cowan, Imelda Tenggara, Martina Maggi, June M. Chan, Matthew R. Cooperberg, Peter Carroll Cribriform pattern, Genomic Prostate Score, and adverse pathology at radical prostatectomy in a cohort of prostate cancer patients initially on active surveillance.  View on PubMed
  18. Ravindranathan A, Cimini B, Diolaiti ME, Stohr BA Preliminary development of an assay for detection of TERT expression, telomere length, and telomere elongation in single cells.  View on PubMed
  19. Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.  View on PubMed
  20. Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.  View on PubMed

Go to UCSF Profiles, powered by CTSI